Product Information
GNP OMEPRAZOLE DR 20 MG TABLET is a generic product labeled by AmerisourceBergen, priced at $0.3832 per EA under NDC 46122073903. Its NADAC has been published 157 times since Oct 4, 2023.
FDA first approved this application on Nov 5, 2018.
Strength
20 mg/1
Manufacturer
AmerisourceBergenNDC
46122073903
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207740FDA Approved
11/5/2018
On Market Since
11/6/2018
Pharmacological Classes
Price Statistics
The NADAC for GNP OMEPRAZOLE DR 20 MG TABLET has been published 157 times since Oct 4, 2023, and over the history we have for it it has declined 2.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3832 per EA |
|---|---|
| All-time high | $0.4584 (Dec 13, 2023) |
| All-time low | $0.3668 (May 22, 2024) |
| 52-week high | $0.4213 |
| 52-week low | $0.3832 |
| Median price | $0.4071 |
| Average price | $0.4101 |
| Largest weekly change | +18.4% (Aug 21, 2024) |
| Weeks tracked | 157 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP OMEPRAZOLE DR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP OMEPRAZOLE DR 20 MG TABLET, manufactured by AmerisourceBergen, is $0.3832 per EA (NDC 46122073903), effective Sep 30, 2026.
How has the price of GNP OMEPRAZOLE DR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for GNP OMEPRAZOLE DR 20 MG TABLET has declined 2.8%. It has been tracked across 157 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for GNP OMEPRAZOLE DR 20 MG TABLET?
Since Oct 4, 2023, the NADAC for GNP OMEPRAZOLE DR 20 MG TABLET has ranged from a low of $0.3668 (May 22, 2024) to a high of $0.4584 (Dec 13, 2023), with a median of $0.4071 per EA.
Are there cheaper alternatives to GNP OMEPRAZOLE DR 20 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP OMEPRAZOLE DR 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP OMEPRAZOLE DR 20 MG TABLET?
GNP OMEPRAZOLE DR 20 MG TABLET (NDC 46122073903) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.